Homeβ€ΊSearchβ€ΊFuture Rare Diseases

Future Rare Diseases

Taylor and Francis Ltd. Β· United Kingdom Β· Est. 2020

ISSN2399-5270
SJR Q4βœ“ Scopus / SJR
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
πŸ“Š Standing in its field
Where this journal ranks among others in the same subject area.
Q4
SJR Β· Scopus
Bottom 25%
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.15
H-Indexi
6
SNIPi
0.226
Total Worksi
137
Total Citationsi
161
2yr Mean Citednessi
0.17
Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Future Rare Diseases is a peer-reviewed, open-access journal that publishes research on rare diseases, clinical disease management, diagnosis, genetic disorders, patient advocacy, and orphan drugs. It serves as a resource for scientists, clinicians, policy makers, and patient advocates to share knowledge and increase exposure for work in rare disease research and treatment development.

AI-compiled from public web sources Β· verify on the publisher page

General Information

Country / RegionUnited Kingdom
Primary Languageβ€”
1st Year Published2020
Annual Volume~ 32 articles / year
StatusActive (last: 2026)
Total Publications137
Publisher OrgFuture Medicine

Submission Info

Peer Reviewβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

4/11 Β· 36%
βœ…
Do you know the journal / publisher?
Taylor and Francis Ltd.
❌
Does the journal have a website?
No URL
βœ…
Is the ISSN verified?
2399-5270
βœ…
Indexed in a trusted database?
Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
❌
Primary language documented?
N/A

A twelfth criterion β€” whether APC fees are clearly disclosed β€” is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
1
2
2020
17
63
2021
14
57
2022
23
40
2023
25
12
2024
47
15
2025
22
1
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Medicine (miscellaneous)Q4

Subject Classification

Scopus Categories

Medicine (miscellaneous)

Research Topics (OpenAlex)

Lysosomal Storage Disorders ResearchGenomics and Rare DiseasesRenal Diseases and GlomerulopathiesGenetics and Neurodevelopmental DisordersFamily and Disability Support ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHemophilia Treatment and ResearchAutism Spectrum Disorder ResearchComplement system in diseasesBlood groups and transfusion

Frequently asked questions about Future Rare Diseases

Is Future Rare Diseases a predatory journal?

PubScope has no integrity flags on record for Future Rare Diseases: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Future Rare Diseases?

Future Rare Diseases is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.15.

Is Future Rare Diseases indexed in Scopus and Web of Science?

Future Rare Diseases is indexed in Scopus.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref